Correlation between the levels of survivin and survivin promoter-driven gene expression in cancer and non-cancer cells

Cellular and Molecular Biology Letters

Volumn 14, Issue 1, 2009, Pages 70-89

  Konopka, Krystyna ^a   Spain, Christopher ^a   Yen, Allison ^a   Overlid, Nathan ^a   Gebremedhin, Senait ^a   Düzgüneş, Nejat ^a  

^a UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

Cmv promoter; Metafectene; Metafectene pro; Non cancer cells; Oral squamous cell carcinoma cells; Survivin; Survivin promoter; Transfection

Indexed keywords

LUCIFERASE; SURVIVIN; BIRC5 PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LYSATE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; KERATINOCYTE; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; ANIMAL; CELL DEATH; CELL STRAIN 3T3; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; TRANSGENE; TUMOR CELL LINE;

CYTOMEGALOVIRUS; MURINAE;

ANIMALS; CELL DEATH; CELL LINE, TUMOR; CYTOMEGALOVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUCIFERASES; MICE; MICROTUBULE-ASSOCIATED PROTEINS; NIH 3T3 CELLS; PROMOTER REGIONS, GENETIC; TRANSFECTION; TRANSGENES;

EID: 58949100017     PISSN: 14258153     EISSN: 16891392     Source Type: Journal    
DOI: 10.2478/s11658-008-0034-5     Document Type: Article

References (62)

1. Hanahan, D. and Weinberg, R.A. The hallmarks of cancer. Cell 100 (2000) 57-70.
2. Evan, G.I. and Vousden, K.H. Proliferation, cell cycle and apoptosis in cancer. Nature 411 (2001) 342-348.
3. Salvesen, G.S. and Duckett, C.S. IAP proteins: blocking the road to death's door. Natl. Rev. Mol. Cell Biol. 3 (2002) 401-410.
4. Li, F. and Altieri, D.C. The caner anti-apoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression. Cancer Res. 59 (1999) 3142-3151. (Pubitemid 29316014)
5. Altieri, D.C. Validating survivin as a cancer therapeutic target. Nat. Rev. Cancer 3 (2003) 46-54. (Pubitemid 37328886)
6. Altieri, D.C. Molecular circuits of apoptosis regulation and cell division control: The survivin paradigm. J. Cell. Biochem. 92 (2004) 656-663.
7. Altieri, D.C. Targeted therapy by disabling crossroad signaling networks: the survivin paradigm. Mol. Cancer Ther. 5 (2006) 478-482.
8. Dohi, T., Beltrami, E., Wall, N.R., Plescia, J. and Altieri, D.C. Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis. J. Clin. Invest. 114 (2004) 1117-1127. (Pubitemid 39578701)
9. Ambrosini, G., Adida, C. and Altieri, D.C. A novel anti-apoptotic gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3 (1997) 917-921. (Pubitemid 27353455)
10. Adida, C., Crotty, P.L., McGrath, J., Berrebi, D., Diebold, J. and Altieri, D.C. Developmentally regulated expression of the novel cancer antiapoptosis gene survivin in human and mouse differentiation. Am. J. Pathol. 152 (1998) 43-49. (Pubitemid 28028045)
11. Fukuda, S. and Pelus, L.M. Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34+ cells by hematopoietic growth factors: Implications of survivin expression in normal hematopoiesis. Blood 98 (2001) 2091-2100. (Pubitemid 33785791)
12. Altieri, D.C. Survivin and apoptosis control. Adv. Cancer Res. 88 (2003) 31-52.
13. Johnson. M.E. and Howerth, E.W. Survivin: a bifunctional inhibitor of apoptosis protein. Vet. Pathol. 41 (2004) 599-607.
14. Lo Muzio, L., Pannone, G., Leonardi, R., Staibano, S., Mignogna, M.D., De Rosa, G., Kudo, Y., Takata, T. and Altieri, D.C. Survivin, a potential early predictor of tumor progression in the oral mucosa. J. Dent. Res. 82 (2003) 923-928. (Pubitemid 41756876)
15. Lo Muzio, L., Pannone, G., Staibano, S., Mignogna, M.D., Rubini, C., Mariggiò, M.A., Procaccini, M., Ferrari, F., De Rosa, G. and Altieri, D.C. Survivin expression in oral squamous cell carcinoma. Brit. J. Cancer 89 (2003) 2244-2248. (Pubitemid 38168006)
16. Lo Muzio, L., Campisi, G., Giovanelli, L., Ammatuna, P., Greco, I., Staibano, S., Pannone, G., De Rosa, G., Di Liberto, C. and D'Angelo. M. HPV DNA and survivin expression in epithelial oral carcinogenesis: a relationship? Oral Oncol. 40 (2004) 736-741. (Pubitemid 38686911)
17. Tanaka, C., Uzawa, K., Shibahara, T., Yokoe, H., Noma, H. and Tanzawa, H. Expression of an inhibitor of apoptosis, survivin, in oral carcinogenesis. J. Dent. Res. 82 (2003) 607-811. (Pubitemid 41766142)
18. Lin, C.Y., Hung, H.C., Kuo, H.C., Chiang, C.P. and Kuo, M.Y. Survivin expression predicts poorer prognosis in patients with areca quid chewingrelated oral squamous cell carcinoma in Taiwan. Oral Oncol. 41 (2005) 645-654.
19. Bao, R., Connolly, D.C., Murphy, M., Green, J., Weinstein, J.K., Pisarcik, D.A. and Hamilton, T. Activation of cancer-specific gene expression by the survivin promoter. J. Natl. Cancer Inst. 94 (2002) 522-528. (Pubitemid 34411291)
20. Chiou, S., Jones, M.K. and Tarnawski, A.S. Survivin- an anti-apoptosis protein: its biological roles and implications for cancer and beyond. Med. Sci. Monit. 9 (2003) P143-P147. (Pubitemid 36565381)
21. Chen, J.S., Liu, J.C., Shen, L., Rau, K.M., Kuo, H.P., Li, Y.M., Shi, D., Lee, Y.C., Chang, K.J. and Hung, M.C. Cancer-specific activation of the survivin promoter and its potential use in gene therapy. Cancer Gene Ther. 11 (2004) 740-747. (Pubitemid 39488472)
22. Scully, C. Oral precancer: preventive and medical approaches to management. Eur. J. Cancer B Oral Oncol. 31(B) (1995) 16-26.
23. Schepman, K., der Meij, E., Smeele, L. and der Waal, I. Concomitant leukoplakia in patients with oral squamous cell carcinoma. Oral. Dis. 5 (1999) 206-209. (Pubitemid 29385764)
24. Choi, S. and Myers, J.N. Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J. Dent. Res. 87 (2007) 14-32.
25. Lo Muzio, L., Staibano, S., Pannone, G., Mignona, M.D., Mariggio, A., Salvatore, G., Chieffi, P., Tramontano, D., De Rosa, G. and Altieri D.C. Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp. Mol. Pathol. 70 (2001) 249-254. (Pubitemid 32607197)
26. Lo Muzio, L. Farina, A., Rubini, C., Pezzetti, F., Stabellini, G., Laino, G., Santarelli, A., Pannone, G., Bufo, P., de Lillo, A. and Carinci, F. Survivin as prognostic factor in squamous cell carcinoma of the oral cavity. Cancer Lett. 225 (2005) 27-33. (Pubitemid 40732765)
27. Harras, A., Edwards, B.K., Blot, W.J. and Ries, L.A. Cancer rates and risks. National Institutes of Health, Bethesda, MD. NIH Publication (1996) No.96-691.
28. Silverman, S. Jr. Oral cancer: complication of therapy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 88 (1999) 122-126.
29. Shillitoe, E.J. Gene therapy for oral cancer: recent progress in research. Oral Oncol. 34 (1998) 157-160. (Pubitemid 28267165)
30. Xi, S. and Grandis, J.R. Gene therapy for the treatment of oral squamous cell carcinoma. J. Dental. Res. 82 (2003) 11-16.
31. Ladeinde, A.L., Ogunlewe, M.O., Adeyemo, W.L. and Bamgbose, B.O. Gene therapy in the management of oral cancer: a review of recent documents. Niger. Postgrad. Med. J. 12 (2005) 18-22.
32. Gibbs J.B. Mechanism based target identification and drug discovery in cancer research. Science 287 (2000) 1969-1973.
33. Hart, I.R. Tissue specific promoters in targeting systemically delivered gene therapy. Semin. Oncol. 23 (1996) 154-158.
34. O'Malley, B.W., Cope, K.A., Chen, S.-H., Li, D., Schwartz, M.R. and Woo, S.L.C. Combination gene therapy for oral cancer in a murine model. Cancer Res. 56 (1996) 1737-1741. (Pubitemid 26118205)
35. O'Malley, B.W., Cope, K.A., Johnson, C.S. and Schwartz, M.R. A new immunocompetent murine model for oral cancer. Arch. Otolaryngol. Head Neck Surg. 123 (1997) 20-24. (Pubitemid 27043653)
36. Yen, A., Overlid, N., Li, F., Düzgüneş N. and Konopka, K. Survivin promoter-driven gene expression in human oral cancer cells. The 85th General Session of the International Association for Dental Research and 36th Annual Meeting of the American Association for Dental Research, New Orleans, LA, 2007, J. Dent. Res. 86 (Special issue A) Abstract No. 0758, Seq. #98.
37. Spain, C., Overlid, N., Li, F., Düzgüneş, N. and Konopka, K. Murine survivin promoter-driven gene expression in cancer and non-tumor cells. International Association for Dental Research and 36th Annual Meeting of the American Association for Dental Research, New Orleans, LA, 2007, J. Dent. Res. 86 (Special issue A) Abstract No. 2394, Seq. #240.
38. Li, F. and Altieri, D.C. Transcriptional analysis of human survivin gene expression. Biochem. J. 344 (1999) 305-311. (Pubitemid 30011584)
39. Yang, L., Cao, Z., Li, F., Post, D.E., Van Meir, E.G., Zhong, H. and Wood, W.C. Tumor-specific gene expression using the survivin promoter is further increased by hypoxia. Gene Ther. 11 (2004) 1215-1223. (Pubitemid 39136785)
40. Zhu, Z.B., Makhija, S.K., Lu, B., Wang, M., Kaliberova, L., Liu, B., Rivera, A.A., Nettelbeck, D.M., Mahasreshti, P.J., Leath III, C.A., Barker, S., Yamaoto, M., Li, F., Alvarez, R.D. and Curiel D.T. Transcriptional targeting of tumors with a novel tumor-specific survivin promoter. Cancer Gene Ther. 11 (2004) 256-262. (Pubitemid 41184344)
41. Matsumoto, K., Horikoshi, M., Rikimaru, K. and Enomoto, S. A study of an in vitro model for invasion of oral squamous cell carcinoma. J. Oral Pathol. Med. 18 (1989) 498-501. (Pubitemid 20064432)
42. Prime, S.S., Nixon, S.V.R., Crane, I.J., Stone, A., Matthews, J.B., Maitland, N.J., Remnant, L., Powell, S.K., Game, S.M. and Scully, C. The behaviour of human oral squamous cell carcinoma in cell culture. J. Pathol. 160 (1990) 259-269. (Pubitemid 20115509)
43. Eagle, H. Propagation in a fluid medium of a human epidermoid carcinoma strain KB. Proc. Soc. Exp. Biol. Med. 89 (1955) 362-364.
44. Gilchrist, E.P., Moyer M.P., Shillitoe, E.J., Clare, N. and Murrah, V.A. Establishment of a human polyclonal oral epithelial cell line. Oral Surg. Oral Med Oral Pathol. Oral Radiol. Endod. 90 (2000) 340-347.
45. Stampfer, M.R. and Bartley, J.C. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzeno(a)pyrene. Proc. Nat. Acad. Sci. 82 (1985) 2394-2398.
46. Walen, K.H. and Stampfer, M.R. Chromosome analyses of human mammary epithelial cells at stages of chemical-induced transformation progression to immortality. Cancer Genet. Cytogenet. 37 (1989) 249-261.
47. Fu, K.K., Rayner, P.A. and Lam, K.N. Modification of the effects of continuous low dose irradiation by concurrent chemotherapy infusion. Int. J. Radiat. Oncol. Biol. Phys. 10 (1984) 1473-1478.
48. Jainchill, J.L., Aaronson, S.A., and Todaro, G.J. Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells. J. Virol. 4 (1969) 549-553.
49. Owens, R.B., Smith, H.S. and Hackett, A.J. Epithelial cell cultures from normal glandular tissue of mice. J. Natl. Cancer Inst. 53 (1974) 261-269.
50. Konopka, K. Fallah, B., Monzon-Duller, J., Overlid, N. and Düzgüneş, N. Serum-resistant gene transfer to oral cancer cells by Metafectene and GeneJammer: Application to HSV-tk/ganciclovir-mediated cytotoxicity. Cell. Mol. Biol. Lett. 10 (2005) 455-470. (Pubitemid 41564518)
51. Fields, R.D. and Lancaster, M.V. Dual-attribute continuous monitoring of cell proliferation/cytotoxicity. Am. Biotechnol. Lab. 11 (1993) 48-50.
52. Konopka, K., Pretzer, E., Felgner, P.L. and Düzgüneş, N. Human immunodeficiency virus type-1 (HIV-1) infection increases the sensitivity of macrophages and THP-1 cells to cytotoxicity by cationic liposomes. Biochim. Biophys. Acta 1312 (1996) 186-196. (Pubitemid 26246516)
53. Konopka, K., Overlid, N., Nagaraj, A.C. and Düzgüneş, N. Serum decreases the size of Metafectene- and GeneJammer-DNA complexes but does not affect significantly their transfection activity in SCCVII squamous cell carcinoma cells. Cell. Mol. Biol. Lett. 11 (2006) 171-190. (Pubitemid 44492476)
54. Bandyopadhyay, A., Cibull, M.L. and Sun, L. Isolation and characterization of a spontaneously transformed mouse mammary epithelial cell line in culture. Carcinogenesis 19 (1998) 1907-1911. (Pubitemid 28521929)
55. Zhu, Z.B., Makhija, S.K., Lu, B., Wang, M., Wang, S., Takayama, K., Siegal, G.P., Reynolds, P.N. and Curiel D.T. Targeting mesothelioma using an infectivity enhanced survivin-conditionally replicative adenoviruses. J. Thorac. Oncol. 1 (2006) 701-711. (Pubitemid 47163960)
56. Li, B., Liu, X., Fan, J., Qi, R., Bo, L., Gu, J., Qian, Q., Qian, C. and Liu, X. A survivin-mediated oncolytic adenovirus induces non-apoptotic cell death in lung cancer cells and shows antitumoral potential in vivo. J. Gene Med. 8 (2006) 1232-1242. (Pubitemid 44660522)
57. Ulasov, I.V., Zhu, Z.B., Tyler, M.A., Han, Y., Rivera, A.A., Khramtsov, A., Curiel, D.T. and Lesniak, M.S. Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma. Hum. Gene Ther. 18 (2007) 589-602. (Pubitemid 47187091)
58. Kamizono, J., Nagano, S., Murofushi, Y., Komiya, S., Fujiwara, H., Matsuishi, T. and Kosai, K. Survivin-responsive conditionally replicating adenovirus exhibits cancer-specific and efficient viral replication. Cancer Res. 65 (2005) 5284-5291. (Pubitemid 40827340)
59. Xu, Y., Fang, F., Ludewig, G., Jones, G. and Jones, D. A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Biol. 23 (2004) 527-537. (Pubitemid 39244331)
60. Jang, J.S., Kim, K.M., Kang, K.H., Choi, J.E., Lee, W.K., Kim, C.H., Kang, Y.M., Kam, S., Kim, I.S., Jun, J.E. and Park, J.Y. Polymorphisms in the survivin gene and the risk of lung cancer. Lung Cancer 60 (2008) 31-39.
61. Borbely, A.A., Murvai, M., Szarka, K., Konya, J., Gergely, L., Hernadi, Z. and Veress, G. Survivin promoter polymorphism and cervical carcinogenesis. J. Clin. Pathol. 60 (2007) 303-306. (Pubitemid 46447748)
62. Kappler, M., Kotzsch, M., Bartel, F., Füssel, S., Lautenschläger, C., Schmidt, U., Würl, P., Bache, M., Schmidt, H., Taubert, H. and Meye, A. Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival. Clin. Cancer Res. 9 (2003) 1098-1104. (Pubitemid 36323717)